Azilsartan medoxomil
Edarbi (azilsartan medoxomil) is a small molecule pharmaceutical. Azilsartan medoxomil was first approved as Edarbi on 2011-02-25. It is used to treat hypertension in the USA. It has been approved in Europe to treat hypertension. Edarbi's patents are valid until 2028-03-26 (FDA).
| Trade Name | Edarbi |
|---|---|
| Common Name | Azilsartan medoxomil |
| Indication | hypertension |
| Drug Class | Angiotensin II receptor antagonists |
